Vaccination program in the response to the 2007 equine influenza outbreak in Australia

Australian Veterinary Journal

Volumn 89, Issue SUPPL.1, 2011, Pages 126-134

  Perkins, N R ^a   Webster, W R ^b   Wright, T ^c   Denney, I ^d   Links, I ^c  

^a AUSVET ANIMAL HEALTH SERVICES   (Australia)

^b DEPARTMENT OF AGRICULTURE AND FISHERIES   (Australia)

^c Industry and Investment NSW   (Australia)

^d Animal Health Australia   (Australia)

Author keywords

Biosecurity; Emergency animal disease; Equine influenza; Horses; Vaccination program

Indexed keywords

INFLUENZA VACCINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; AUSTRALIA; EPIDEMIC; HORSE; HORSE DISEASE; IMMUNOLOGY; INFLUENZA VIRUS A H3N8; METHODOLOGY; ORTHOMYXOVIRUS INFECTION; STANDARD; VACCINATION; VIROLOGY;

ANIMALS; AUSTRALIA; DISEASE OUTBREAKS; HORSE DISEASES; HORSES; INFLUENZA A VIRUS, H3N8 SUBTYPE; INFLUENZA VACCINES; ORTHOMYXOVIRIDAE INFECTIONS; VACCINATION;

ANIMALIA; EQUIDAE;

EID: 79959798377     PISSN: 00050423     EISSN: 17510813     Source Type: Journal    
DOI: 10.1111/j.1751-0813.2011.00766.x     Document Type: Article

References (13)

1. Animal Health Australia. Disease strategy: EI (Version 3.0). In: Australian Veterinary Emergency Plan (AUSVETPLAN). Edn 3. Primary Industries Ministerial Council, Canberra, 2007.
2. Watson J, Halpin K, Selleck P etal. Isolation and characterisation of an H3N8 equine influenza virus in Australia, 2007. Aust Vet J 2011;89(Suppl 1):35-37.
3. OIE. Protecting the world from emerging diseases. OIE Bull 2007;2:41-42. Accessed 1 July 2010.
4. Toulemonde CE, Daly J, Sindle T etal. Efficacy of a recombinant EI vaccine against challenge with an American lineage H3N8 influenza virus responsible for the 2003 outbreak in the United Kingdom. Vet Rec 2005;156:367-371.
5. Paillot R, Kydd JH, Sindle T etal. Antibody and IFN-gamma responses induced by a recombinant canary pox vaccine and challenge infection with EI virus. Vet Immunol Immunopathol 2006;112:225-233.
6. Minke JM, Toulemonde CE, Coupier H etal. Efficacy of a canary pox-vectored recombinant vaccine expressing the haemagglutinin gene of EI H3N8 virus in the protection of ponies from viral challenge. Am J Vet Res 2007;68:213-219.
7. Minke JM, Toulemonde CE, Dinic S etal. Effective priming of foals born to immune dams against influenza by a canary pox-vectored recombinant influenza H3N8 vaccine. J Comp Pathol 2007;137:S76-S80.
8. Guthrie AJ. EI in South Africa, 2003 outbreak. In: Proceedings of the 9th Congress of the World Equine Veterinary Association, 22-26 January 2006, Marrakech, Morocco.
9. Kirkland PD, Delbridge G. Use of a blocking ELISA for antibodies to equine influenza virus as a test to distinguish between naturally infected and vaccinated horses: proof of concept studies. Aust Vet J 2011;89(Suppl 1):45-46.
10. Animal Health Australia. 2007 EI outbreak emergency vaccination protocol for ProteqFlu and ProteqFlu TE vaccines, Version 2, 16 October 2007 [unpublished guideline].
11. Webster WR. The August 2007 equine influenza response management framework. Aust Vet J 2011;89(Suppl 1):92-97.
12. Kannegieter NJ, Frogley A, Crispe E, Kirkland PD. Clinical outcomes and virology of equine influenza in a naïve population and in horses infected soon after receiving one dose of vaccine. Aust Vet J 2011;89(Suppl 1):139-142.
13. Garner MG, Cowled B, East I, Moloney B, Kung N. Evaluating the effectiveness of vaccination in the control and eradication of equine influenza: a modelling approach. Prev Vet Med Mar 15 2010 [Epub ahead of print].